Jennie Y. Law, MD

• Rice University, Houston, TX: B.A. Biology and History
• University of Maryland School of Medicine, Baltimore, MD: M.D.
• University of Maryland Medical Center, Baltimore, MD: Internal Medicine Residency
• UT Southwestern, Dallas, TX: Hematology/Oncology Fellowship

Tam T, Baer MR, Hsu LL, Law JY. An electronic teaching module for improving knowledge of self-management of vaso-occlusive pain crises in patients with sickle cell disease: Pilot questionnaire study. JMIR Mhealth Uhealth. 2019 June 20;7:e13501.

Lee MH, Wilding E, Law JY. A new brain mass in an immunocompromised woman. JAMA Oncol. 2019 Jun 27. [Epub ahead of print].

Patel A, Williams H, Baer MR, Zimrin AB, Law JY. Decreased bleeding incidence with Direct Oral Anticoagulants compared to Vitamin K Antagonist and Low-Molecular-Weight Heparin in patients with sickle cell disease and venous thromboembolism. Acta Haematol. 2019 May 20:1-6. [Epub ahead of print].

Pecker LH, Maher JY, Law JY, Beach MC, Lanzkron S, Christianson MS. Risk factors associated fertility preeservation for women with sickle cell anemia. Fertil Steril. 2018;110:720-731.

Bade NA, Giffi VS, Baer MR, Zimrin AB, Law JY. Thrombotic microangiopathy in the setting of human immunodeficiency virus infection: High incidence of severe thrombocytopenia. J Clin Apher. 2018;33:342-348.

Nakhoda S, Zimrin AB, Baer MR, Law JY. Use of the APACHE II score to assess impact of therapeutic plasma exchange for critically ill patients with hypertriglyceride-induced pancreatitis. Transfus Apher Sci. 2017;56:123-126.